Ghostwriting: The Dirty Little Secret of Medical Publishing That Just Got Bigger
Author
Abstract
Suggested Citation
DOI: 10.1371/journal.pmed.1000156
Download full text from publisher
References listed on IDEAS
- The PLoS Medicine Editors, 2009. "An Unbiased Scientific Record Should Be Everyone's Agenda," PLOS Medicine, Public Library of Science, vol. 6(2), pages 1-3, February.
- Peter C Gøtzsche & Asbjørn Hróbjartsson & Helle Krogh Johansen & Mette T Haahr & Douglas G Altman & An-Wen Chan, 2007. "Ghost Authorship in Industry-Initiated Randomised Trials," PLOS Medicine, Public Library of Science, vol. 4(1), pages 1-6, January.
- Sergio Sismondo, 2007. "Ghost Management: How Much of the Medical Literature Is Shaped Behind the Scenes by the Pharmaceutical Industry?," Working Papers id:1254, eSocialSciences.
- Peter C Gøtzsche & Jerome P Kassirer & Karen L Woolley & Elizabeth Wager & Adam Jacobs & Art Gertel & Cindy Hamilton, 2009. "What Should Be Done To Tackle Ghostwriting in the Medical Literature?," PLOS Medicine, Public Library of Science, vol. 6(2), pages 1-4, February.
Most related items
These are the items that most often cite the same works as this one and are cited by the same works as this one.- Sismondo, Sergio, 2008. "How pharmaceutical industry funding affects trial outcomes: Causal structures and responses," Social Science & Medicine, Elsevier, vol. 66(9), pages 1909-1914, May.
- Nadine Desrochers & Adèle Paul‐Hus & Jen Pecoskie, 2017. "Five decades of gratitude: A meta‐synthesis of acknowledgments research," Journal of the Association for Information Science & Technology, Association for Information Science & Technology, vol. 68(12), pages 2821-2833, December.
- S Scott Graham & Zoltan P Majdik & Dave Clark & Molly M Kessler & Tristin Brynn Hooker, 2020. "Relationships among commercial practices and author conflicts of interest in biomedical publishing," PLOS ONE, Public Library of Science, vol. 15(7), pages 1-11, July.
- Kirmayer, Laurence J., 2012. "Cultural competence and evidence-based practice in mental health: Epistemic communities and the politics of pluralism," Social Science & Medicine, Elsevier, vol. 75(2), pages 249-256.
- Ebeling, Mary, 2011. "'Get with the Program!': Pharmaceutical marketing, symptom checklists and self-diagnosis," Social Science & Medicine, Elsevier, vol. 73(6), pages 825-832, September.
- Unruh, Lynn & Rice, Thomas & Rosenau, Pauline Vaillancourt & Barnes, Andrew J., 2016. "The 2013 cholesterol guideline controversy: Would better evidence prevent pharmaceuticalization?," Health Policy, Elsevier, vol. 120(7), pages 797-808.
- Cédric Brun & Steeves Demazeux & Pierangelo Di Vittorio & François Gonon & Philippe Gorry & Jan Peter Konsman & Fanny Lung & Yannick Lung & Michel Minard & Matthieu Montalban & Nicole Rumeau & Andy Sm, 2015. "Construction of mental health categories [La construction des catégories diagnostiques de maladie mentale]," Post-Print hal-02195583, HAL.
- Jonathan M. Levitt & Mike Thelwall, 2016. "Long term productivity and collaboration in information science," Scientometrics, Springer;Akadémiai Kiadó, vol. 108(3), pages 1103-1117, September.
- Tom Latten & Daan Westra & Federica Angeli & Aggie Paulus & Marleen Struss & Dirk Ruwaard, 2018. "Pharmaceutical companies and healthcare providers: Going beyond the gift – An explorative review," PLOS ONE, Public Library of Science, vol. 13(2), pages 1-15, February.
- Marc-André Gagnon & Joel Lexchin, 2008. "The Cost of Pushing Pills: A New Estimate of Pharmaceutical Promotion Expenditures in the United States," PLOS Medicine, Public Library of Science, vol. 5(1), pages 1-5, January.
- David Pontille & Didier Torny, 2013. "Behind the scenes of scientific articles: defining categories of fraud and regulating cases," CSI Working Papers Series 031, Centre de Sociologie de l'Innovation (CSI), Mines ParisTech.
- Simon Stern & Trudo Lemmens, 2011. "Legal Remedies for Medical Ghostwriting: Imposing Fraud Liability on Guest Authors of Ghostwritten Articles," PLOS Medicine, Public Library of Science, vol. 8(8), pages 1-5, August.
- John P A Ioannidis, 2008. "Measuring Co-Authorship and Networking-Adjusted Scientific Impact," PLOS ONE, Public Library of Science, vol. 3(7), pages 1-8, July.
- Thelwall, Mike & Sud, Pardeep, 2016. "National, disciplinary and temporal variations in the extent to which articles with more authors have more impact: Evidence from a geometric field normalised citation indicator," Journal of Informetrics, Elsevier, vol. 10(1), pages 48-61.
- Ferrán Catalá-López & Gabriel Sanfélix-Gimeno & Manuel Ridao & Salvador Peiró, 2013. "When Are Statins Cost-Effective in Cardiovascular Prevention? A Systematic Review of Sponsorship Bias and Conclusions in Economic Evaluations of Statins," PLOS ONE, Public Library of Science, vol. 8(7), pages 1-1, July.
- Salandra, Rossella, 2018. "Knowledge dissemination in clinical trials: Exploring influences of institutional support and type of innovation on selective reporting," Research Policy, Elsevier, vol. 47(7), pages 1215-1228.
- Adriane Fugh-Berman, 2013. "How Basic Scientists Help the Pharmaceutical Industry Market Drugs," PLOS Biology, Public Library of Science, vol. 11(11), pages 1-5, November.
- Brun, Cédric & Demazeux, Steeves & Vittorio, Pierangelo Di & Gonon, François & Gorry, Philippe & Konsman, Jan Peter & Lung, Fanny & Lung, Yannick & Minard, Michel & Montalban, Matthieu & Rumeau, Nicol, 2015. "La construction des catégories diagnostiques de maladie mentale," Revue de la Régulation - Capitalisme, institutions, pouvoirs, Association Recherche et Régulation, vol. 17.
- Jesse R. Catlin & Cornelia (Connie) Pechmann, 2016. "An Investigation of Consumer and Doctor Regulatory Beliefs and Regulatory Knowledge about Pharmaceutical Drug Promotions," Journal of the Association for Consumer Research, University of Chicago Press, vol. 1(3), pages 392-410.
- Ridha Chakroun & Frédéric Teulon, 2014. "Whistleblowers in the pharmaceutical industry: tragic hero, black sheep or alter ego ?," Working Papers 2014-118, Department of Research, Ipag Business School.
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:plo:pmed00:1000156. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: plosmedicine (email available below). General contact details of provider: https://journals.plos.org/plosmedicine/ .
Please note that corrections may take a couple of weeks to filter through the various RePEc services.